Clinical Trial Update: A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying a fixed-dose combination therapy for Dry Eye Disease is currently recruiting, sponsored by Bausch & Lomb Incorporated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye Disease | Phase 2 | Status: RECRUITING